Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 636 participants.

Also called NCT01620788

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 636 participants (planned count) (from the registry)
Sponsor
EMS (from the registry)
Registry
  • NCT NCT01620788
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT01620788. Randomized; no masking; primary purpose treatment. Start 2019-11-27 (actual); primary completion 2023-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
Condition
Hypertension
Intervention (Drug)
Indapamide / Losartan
Intervention (Drug)
Indapamide / Losartan
Intervention (Drug)
Hyzaar®
Intervention (Drug)
Hyzaar®
Lead sponsor
EMS (class: industry)

Record details

Record id
cardio:ct-nct01620788
Content hash
c8b148b6f8303272e25b9c806a8c9dd1c092217e9194a572a11741d0d1db73aa